Skip to main content

MPLT- Maplight Therapeutics, Inc.

Over the past 90 days, insiders at Maplight Therapeutics, Inc. (MPLT) have been net buyers, picking up 781,693 shares worth roughly $793K on balance. In the past 30 days, 2 insiders bought and 6 sold.

Leading the buying is Catalyst4, Inc. (10% Owner), now holding an estimated $271.8M in MPLT.

Not all activity pointed one way: 6 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MPLT's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
10%20.91M$250.46M+1.21M
CEO1.25M$14.93M-147,639
CFO387.8K$4.65M-
Dir358.2K$4.29M-
Other298.9K$3.58M-47,158

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Aug 3, 2026Lillie James WoodruffChief Scientific OfficerSell22,082$12.54$276,908.28-9.8%--
Jul 30, 2026Catalyst4, Inc.10% OwnerBuy1,209,225$12.66$15,314,793.77+1.5%--
Jul 28, 2026Cox TroyDirectorBuy15,620$9.52$148,702.40New--
Jul 17, 2026Kroeger Christopher A.Chief Executive OfficerSell147,639$36.87$5,443,721.84-1.6%--
Jul 17, 2026Lillie James WoodruffChief Scientific OfficerSell18,267$36.88$673,636.18-1.1%--
Jul 17, 2026Hanson KristopherGeneral CounselSell16,508$36.82$607,870.19-1.5%--
Jul 17, 2026Foff Erin PennockChief Medical OfficerSell47,158$36.78$1,734,490.12-1.6%--
Jul 17, 2026Kreitzer AnatolChief Discovery OfficerSell36,284$37.09$1,345,893.62-2.7%--
Jul 17, 2026Gillis JonathanCAO And Interim CFOSell36,979$37.12$1,372,668.01-3.2%--
May 18, 2026Kroeger Christopher A.Chief Executive OfficerSell118,235$27.19$3,214,999.73-4.1%--
Page 1Next →

Understand these filings